A research agenda for non-communicable disease prevention and control in India.

Control Delphi Health System Strengthening India Integrated Care Non-communicable diseases Prevention Primary Care Snow Card Universal Health Coverage

Journal

Health research policy and systems
ISSN: 1478-4505
Titre abrégé: Health Res Policy Syst
Pays: England
ID NLM: 101170481

Informations de publication

Date de publication:
30 Oct 2020
Historique:
received: 05 12 2019
accepted: 30 09 2020
entrez: 30 10 2020
pubmed: 31 10 2020
medline: 29 7 2021
Statut: epublish

Résumé

Non-communicable diseases contribute to 62% of total deaths in India; of concern are the preventable premature deaths, which account for a staggering 48% of mortality. The objective of this study was to establish a consensus research agenda for non-communicable disease prevention and control that has the potential to impact polices, programmes and healthcare delivery in India. To develop a non-communicable disease research agenda, we engaged our community collaborative board and scientific advisory group in a three-step process using two web-based surveys and one in-person meeting. First, the Delphi methodology was used to generate topics. Second, these ideas were deliberated upon during the in-person meeting, leading to the prioritisation of 23 research questions, which were subjected to Strength, Weakness, Opportunities and Threat analysis by the stakeholders using the Snow Card methodology with the scientific advisory group and community collaborative board. This step resulted in the identification of 15 low effort, high impact priority research questions for various health outcomes across research disciplines based on discussion with the larger group to reach consensus. Finally, the second web-based survey resulted in the identification of 15 key priority research questions by all stakeholders as being the most important using a linear mixed effect regression model. The final set of 15 priority research questions focused on interventions at the individual, community, systems and policy levels. Research questions focused on identifying interventions that strengthen healthcare systems and healthcare delivery, including models of care and improved access to non-communicable disease screening, diagnosis and treatment, determining the impact of government policies, assessing the effectiveness of prevention programmes (e.g. tobacco, environmental improvements), and testing research tools and resources to monitor non-communicable diseases at the population level. To produce the evidence base for selecting and implementing non-communicable disease programmes and policies in India, investments are needed. These investments should be guided by a national research agenda for the prevention and control of non-communicable diseases in India. Our findings could form the backbone of a national research agenda for non-communicable diseases in India that could be refined and then adopted by government agencies, the private sector, non-governmental and community-based organisations.

Sections du résumé

BACKGROUND BACKGROUND
Non-communicable diseases contribute to 62% of total deaths in India; of concern are the preventable premature deaths, which account for a staggering 48% of mortality. The objective of this study was to establish a consensus research agenda for non-communicable disease prevention and control that has the potential to impact polices, programmes and healthcare delivery in India.
METHODS METHODS
To develop a non-communicable disease research agenda, we engaged our community collaborative board and scientific advisory group in a three-step process using two web-based surveys and one in-person meeting. First, the Delphi methodology was used to generate topics. Second, these ideas were deliberated upon during the in-person meeting, leading to the prioritisation of 23 research questions, which were subjected to Strength, Weakness, Opportunities and Threat analysis by the stakeholders using the Snow Card methodology with the scientific advisory group and community collaborative board. This step resulted in the identification of 15 low effort, high impact priority research questions for various health outcomes across research disciplines based on discussion with the larger group to reach consensus. Finally, the second web-based survey resulted in the identification of 15 key priority research questions by all stakeholders as being the most important using a linear mixed effect regression model.
RESULTS RESULTS
The final set of 15 priority research questions focused on interventions at the individual, community, systems and policy levels. Research questions focused on identifying interventions that strengthen healthcare systems and healthcare delivery, including models of care and improved access to non-communicable disease screening, diagnosis and treatment, determining the impact of government policies, assessing the effectiveness of prevention programmes (e.g. tobacco, environmental improvements), and testing research tools and resources to monitor non-communicable diseases at the population level.
CONCLUSION CONCLUSIONS
To produce the evidence base for selecting and implementing non-communicable disease programmes and policies in India, investments are needed. These investments should be guided by a national research agenda for the prevention and control of non-communicable diseases in India. Our findings could form the backbone of a national research agenda for non-communicable diseases in India that could be refined and then adopted by government agencies, the private sector, non-governmental and community-based organisations.

Identifiants

pubmed: 33121498
doi: 10.1186/s12961-020-00639-0
pii: 10.1186/s12961-020-00639-0
pmc: PMC7597004
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

126

Subventions

Organisme : NCI NIH HHS
ID : P20CA210298
Pays : United States

Références

Prog Community Health Partnersh. 2013 Fall;7(3):331-9
pubmed: 24056515
J Family Med Prim Care. 2017 Oct-Dec;6(4):701-708
pubmed: 29564247
Iran J Public Health. 2012;41(3):1-8
pubmed: 23113144
Bull World Health Organ. 2012 Jan 1;90(1):20-9
pubmed: 22271961
Lancet. 2017 Dec 2;390(10111):2437-2460
pubmed: 29150201
Lancet Glob Health. 2018 Dec;6(12):e1262-e1263
pubmed: 30292427
Asian Pac J Cancer Prev. ;18(7):2005-2010
pubmed: 28749643

Auteurs

Ishu Kataria (I)

Center for Global Noncommunicable Diseases, RTI International, New Delhi, India. ikataria@rti.org.

Mariam Siddiqui (M)

Center for Global Noncommunicable Diseases, RTI International, New Delhi, India.

Theresa Gillespie (T)

Winship Cancer Institute, Department of Surgery, Emory University, Atlanta, GA, United States of America.

Michael Goodman (M)

Rollins School of Public Health, Department of Epidemiology, Emory University, Atlanta, GA, United States of America.

Preet K Dhillon (PK)

Center for Chronic Disease Control and Public Health Foundation of India, New Delhi, India.

Carla Bann (C)

RTI International, Durham, NC, United States of America.

Linda Squiers (L)

RTI International, Durham, NC, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH